These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31646656)

  • 1. Dipeptidyl peptidase-4 inhibitor-associated anti-laminin-γ1 (p200) pemphigoid in a patient with psoriasis vulgaris.
    Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Kayaba H; Sawamura D
    J Dermatol; 2020 Jan; 47(1):e25-e26. PubMed ID: 31646656
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration.
    Nakatani K; Noborio R; Nomura Y; Ueki Y; Kiyohara T; Hashimoto T
    J Dermatol; 2024 Jun; 51(6):869-872. PubMed ID: 38214494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
    Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
    J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case of anti-laminin-gamma1 pemphigoid associated with psoriatic erythroderma.
    Kaminaka C; Kanazawa N; Furukawa F; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):272-5. PubMed ID: 20507394
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-p200 Pemphigoid: A Systematic Review.
    Kridin K; Ahmed AR
    Front Immunol; 2019; 10():2466. PubMed ID: 31695695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
    Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid showing positive autoantibody responses to multiple epitopes.
    Kitao R; Fukumoto T; Hashimoto T; Izumi K; Jimbo H; Takemori C; Nishigori C
    J Dermatol Sci; 2021 Sep; 103(3):190-192. PubMed ID: 34489165
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
    Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
    Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
    [No Abstract]   [Full Text] [Related]  

  • 9. Βullous pemphigoid in patients with DPP-4 inhibitors at the onset of disease: does this differ from common bullous pemphigoid?
    Patsatsi A; Kyriakou A; Meltzanidou P; Trigoni A; Lamprou F; Kokolios M; Giannakou A
    Eur J Dermatol; 2018 Oct; 28(5):711-713. PubMed ID: 30325322
    [No Abstract]   [Full Text] [Related]  

  • 10. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y; Nishie W; Izumi K; Shimizu H
    Front Immunol; 2019; 10():1224. PubMed ID: 31191560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope-spreading phenomena in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid.
    García-Díez I; España A; Iranzo P
    Br J Dermatol; 2019 May; 180(5):1267-1268. PubMed ID: 30675718
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-p200 pemphigoid.
    Goletz S; Hashimoto T; Zillikens D; Schmidt E
    J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anti-BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid: a report of three patients.
    Mai Y; Nishie W; Izumi K; Yoshimoto N; Morita Y; Watanabe M; Toyonaga E; Ujiie H; Iwata H; Fujita Y; Nomura T; Sato-Matsumura KC; Shimizu S; Shimizu H
    Br J Dermatol; 2018 Sep; 179(3):790-791. PubMed ID: 29624639
    [No Abstract]   [Full Text] [Related]  

  • 14. Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
    Chijiwa C; Takeoka S; Kamata M; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Watanabe S; Tada Y
    J Dermatol; 2018 May; 45(5):596-599. PubMed ID: 29411416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid, likely triggered by scabies, in a hemodialysis patient with human leukocyte antigen-DQB1*03:01.
    Hibi A; Kasahara Y; Ishihara Y; Hata K; Hosokawa N; Nakagawa T
    CEN Case Rep; 2020 Aug; 9(3):189-194. PubMed ID: 31993957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous pemphigoid with dipeptidyl peptidase-4 inhibitors: Clinical features and pathophysiology.
    Murakami T; Yabe D; Inagaki N
    J Diabetes Investig; 2019 Sep; 10(5):1168-1170. PubMed ID: 30989811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-p200/laminin γ1 pemphigoid associated with metastatic oesophageal cancer.
    Goetze S; Dumke AK; Zillikens D; Hipler UC; Elsner P
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):e219-e221. PubMed ID: 27684497
    [No Abstract]   [Full Text] [Related]  

  • 18. A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis.
    Majima Y; Yagi H; Tateishi C; Groth S; Schmidt E; Zillikens D; Koga H; Hashimoto T; Tokura Y
    Br J Dermatol; 2013 Jun; 168(6):1367-9. PubMed ID: 23252972
    [No Abstract]   [Full Text] [Related]  

  • 19. Exacerbation of well-controlled bullous pemphigoid by the administration of a dipeptidyl peptidase-4 inhibitor.
    Nishiyama C; Tateishi C; Hashimoto T; Nishida M; Imanishi A; Shiratori T; Maekawa N; Tsuruta D; Fukai K
    Clin Exp Dermatol; 2019 Oct; 44(7):830-832. PubMed ID: 30859617
    [No Abstract]   [Full Text] [Related]  

  • 20. Gliptin-associated Bullous Pemphigoid and the Expression of Dipeptidyl Peptidase-4/CD26 in Bullous Pemphigoid.
    Lindgren O; Varpuluoma O; Tuusa J; Ilonen J; Huilaja L; Kokkonen N; Tasanen K
    Acta Derm Venereol; 2019 May; 99(6):602-609. PubMed ID: 30848289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.